WOOREE BIO CO., LTD Q3 revenue KRW 350.2 billion, operating loss of KRW 5.1 billion, turning to a loss
AI summary · Not investment advice
Woori Bio sold KRW 350.2 billion worth in Q3 but lost KRW 5.1 billion from its main business, turning from a profit a year earlier to a loss.
Operating profit · 3 months
KRW -5.1 billion
Key facts
- Revenue (3 months)
- KRW 350.2 billion
- Net income (3 months)
- KRW -18.4 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 263.9 billion
- Revenue (year to date)
- KRW 935.8 billion
- Operating profit (prior-year 3 months)
- KRW 2.4 billion
- Operating profit (year to date)
- KRW -11.9 billion
- Net income (prior-year 3 months)
- KRW 2.7 billion
- Net income (year to date)
- KRW -20.8 billion
Commentary
AI commentary · Not investment advice
What happened
Woori Bio reported its 3rd-quarter results on a consolidated basis. Sales for the latest 3 months were KRW 350.2 billion. That is 32.7% higher than the same 3 months a year earlier (KRW 263.9 billion). It is also 10.7% higher than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 5.1 billion. A year earlier, the company made a profit of KRW 2.4 billion. It has now turned to a loss.
What changes for shareholders
Net income (the final profit after taxes and all other costs) for the 3 months was a loss of KRW 18.4 billion. A year earlier, it was a profit of KRW 2.7 billion. This also turned to a loss.
For the year so far (January 1 to September 30), sales were KRW 935.8 billion. Operating profit was a loss of KRW 11.9 billion. Net income was a loss of KRW 20.8 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
W